Medication Review Video Module: What is the safety profile of upadacitinib across indications?

RhAPPcast

Jessica Farrell, PharmD, reviews a key study on the safety profile of upadacitinib in patients with RA, psoriatic arthritis, and atopic dermatitis. She highlights important findings on adverse events, including herpes zoster, serious infections, and cardiovascular risks. This Medication Review offers insights into the safety of upadacitinib based on 15,000+ patient-years of data, helping clinicians and patients make informed decisions.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada